• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild-to-moderate asthma. The SKY study.

作者信息

Lavorini Federico, Matucci Andrea, Rossi Oliviero, Pistolesi Massimo

机构信息

Department Experimental and Clinical Medicine, University of Florence Italy, Florence, Italy.

Immonoallergology Unit, Careggi University Hospital, Florence, Italy.

出版信息

Allergy. 2020 Mar;75(3):675-677. doi: 10.1111/all.14007. Epub 2019 Oct 24.

DOI:10.1111/all.14007
PMID:31376160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7078869/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f6d/7078869/88b49e3da609/ALL-75-675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f6d/7078869/4d2b73a8b3d6/ALL-75-675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f6d/7078869/88b49e3da609/ALL-75-675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f6d/7078869/4d2b73a8b3d6/ALL-75-675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f6d/7078869/88b49e3da609/ALL-75-675-g002.jpg

相似文献

1
Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild-to-moderate asthma. The SKY study.比拉斯汀与孟鲁司特联合作为季节性变应性鼻结膜炎和轻至中度哮喘的附加疗法。SKY研究。
Allergy. 2020 Mar;75(3):675-677. doi: 10.1111/all.14007. Epub 2019 Oct 24.
2
Risk Assessment-Based Enhanced Analytical Quality-by-Design Approach to Eco-Friendly and Economical Multicomponent Spectrophotometric Methods for Simultaneous Estimation of Montelukast Sodium and Bilastine.基于风险评估的增强型分析质量设计方法，用于生态友好和经济的多组份分光光度法同时测定孟鲁司特钠和比拉斯汀。
J AOAC Int. 2021 Sep 27;104(5):1453-1463. doi: 10.1093/jaoacint/qsab089.
3
Should we use montelukast in wheezy children?我们应该给喘息儿童使用孟鲁司特吗？
Arch Dis Child. 2017 Nov;102(11):997-998. doi: 10.1136/archdischild-2017-312655. Epub 2017 Aug 5.
4
Montelukast sodium combined with budesonide for cough variant asthma in children.孟鲁司特钠联合布地奈德治疗儿童咳嗽变异性哮喘。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):2295-2297. doi: 10.23812/20-301-L.
5
[What is the role of montelukast in asthma treatment?].[孟鲁司特在哮喘治疗中的作用是什么？]
Tuberk Toraks. 2020 Sep;68(3):328-330. doi: 10.5578/tt.69801.
6
lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma.lncRNA PCGEM1 增强孟鲁司特钠对咳嗽变异性哮喘患儿的抗炎和肺保护作用。
Braz J Med Biol Res. 2020 Jun 5;53(7):e9271. doi: 10.1590/1414-431X20209271. eCollection 2020.
7
Montelukast: UK regulator says asthma drug needs clearer warnings of side effects.孟鲁司特：英国监管机构称哮喘药物需要更明确的副作用警告。
BMJ. 2024 May 8;385:q1048. doi: 10.1136/bmj.q1048.
8
Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.在一个州的医疗补助计划中，对于儿童和青少年的哮喘和过敏性鼻炎，孟鲁司特的预先授权政策对临床结果的影响。
J Manag Care Spec Pharm. 2014 Jun;20(6):612-21. doi: 10.18553/jmcp.2014.20.6.612.
9
Montelukast in general pediatric practices.孟鲁司特在普通儿科实践中的应用
J Med Assoc Thai. 2005 Sep;88 Suppl 4:S348-51.
10
PP-ICONS--another tool to help interpret asthma utilization studies.PP-ICONS——另一种有助于解读哮喘使用情况研究的工具。
J Manag Care Pharm. 2006 May;12(4):341-2. doi: 10.18553/jmcp.2006.12.4.341.

引用本文的文献

1
Expert Panel Consensus Recommendations for Allergic Rhinitis in Patients with Asthma in India.印度哮喘患者过敏性鼻炎专家小组共识推荐
Pulm Ther. 2025 Jun;11(2):129-155. doi: 10.1007/s41030-024-00273-z. Epub 2024 Oct 17.
2
Development of a green synchronous spectrofluorimetric technique for simultaneous determination of Montelukast sodium and Bilastine in pharmaceutical formulations.开发一种用于同时测定药物制剂中孟鲁司特钠和比拉斯汀的绿色同步荧光光谱技术。
BMC Chem. 2024 Jan 25;18(1):18. doi: 10.1186/s13065-024-01116-3.
3
Green quality by design HPLC approach for the simultaneous determination of Bilastine and Montelukast.

本文引用的文献

1
Bilastine: new insight into antihistamine treatment.比拉斯汀：抗组胺治疗的新见解。
Clin Mol Allergy. 2015 Apr 15;13(1):1. doi: 10.1186/s12948-015-0008-x. eCollection 2015.
2
Single-dose desloratadine and montelukast and allergen-induced late airway responses.单剂量地氯雷他定和孟鲁司特与变应原诱导的迟发性气道反应
Eur Respir J. 2009 Jun;33(6):1302-8. doi: 10.1183/09031936.00169008. Epub 2009 Jan 22.
3
Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.20毫克比拉斯汀与5毫克地氯雷他定治疗季节性变应性鼻炎患者的疗效和安全性比较。
绿色设计质量的高效液相色谱法同时测定比拉斯汀和孟鲁司特
BMC Chem. 2023 May 2;17(1):43. doi: 10.1186/s13065-023-00953-y.
4
Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions.10毫克和20毫克比拉斯汀在儿科和成人患者中的应用：治疗决策的最新实用方法
Drugs Context. 2021 Aug 10;10. doi: 10.7573/dic.2021-5-1. eCollection 2021.
5
Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.孟鲁司特通过改变实验性自身免疫性脑脊髓炎小鼠模型中的 Th17 分化来缓解炎症。
Immunology. 2021 Jun;163(2):185-200. doi: 10.1111/imm.13308. Epub 2021 Feb 28.
Allergy. 2009 Jan;64(1):158-65. doi: 10.1111/j.1398-9995.2008.01813.x.
4
Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen.
J Allergy Clin Immunol. 2005 Oct;116(4):768-72. doi: 10.1016/j.jaci.2005.06.014. Epub 2005 Aug 19.
5
Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.孟鲁司特，一种白三烯受体拮抗剂，与氯雷他定，一种组胺受体拮抗剂联合使用，用于治疗慢性哮喘。
Arch Intern Med. 2000 Sep 11;160(16):2481-8. doi: 10.1001/archinte.160.16.2481.
6
Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.比较每日一次服用120毫克盐酸非索非那定、10毫克氯雷他定和安慰剂治疗季节性变应性鼻炎的疗效、安全性及生活质量。
Clin Exp Allergy. 2000 Jun;30(6):891-9. doi: 10.1046/j.1365-2222.2000.00914.x.
7
Induced sputum eicosanoid concentrations in asthma.哮喘患者诱导痰中类花生酸的浓度
Am J Respir Crit Care Med. 1999 Dec;160(6):1905-9. doi: 10.1164/ajrccm.160.6.9903114.
8
Allergic rhinitis and asthma: how important is the link?过敏性鼻炎与哮喘：二者的关联有多重要？
J Allergy Clin Immunol. 1997 Feb;99(2):S781-6. doi: 10.1016/s0091-6749(97)70127-1.
9
Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects.白三烯和组胺介导人支气管的IgE依赖性收缩：从哮喘和非哮喘受试者组织获得的药理学证据。
Pulm Pharmacol. 1993 Mar;6(1):87-96. doi: 10.1006/pulp.1993.1012.
10
Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.支气管内过敏原激发后，特应性哮喘患者支气管肺泡灌洗液中白三烯C4水平升高。
Am Rev Respir Dis. 1990 Jul;142(1):112-9. doi: 10.1164/ajrccm/142.1.112.